Apr 30, 2012
This podcast reviews the results of the FACT trial in the context of other ongoing and proposed studies of endocrine therapy combinations.
Apr 30, 2012
This podcast describes a phase 2 trial brentuximab vedotin in patients with Hodgkin lymphoma that has recurred after autologous hematopoietic stem cell transplantation. The podcast discusses the rationale for the trial, response to therapy, and associated toxicities. Future application of brentuximab vedotin to...
Apr 23, 2012
In this study, the implications of long term follow up of the German Rectal Study on clinical practice and future trial design will be discussed.
Apr 23, 2012
Carboplatin-Gemcitabine-Bevacizumab represents an additional regimen to consider for management of recurrent platinum sensitive epithelial ovarian cancer, although it raises several questions regarding the role of bevacizumab in this disease setting.